SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-286789
Filing Date
2021-09-29
Accepted
2021-09-29 16:26:28
Documents
5
Effectiveness Date
2021-09-29

Document Format Files

Seq Description Document Type Size
1 S-8 d230923ds8.htm S-8 48399
2 EX-4.3 d230923dex43.htm EX-4.3 121851
3 EX-5.1 d230923dex51.htm EX-5.1 9028
4 EX-23.1 d230923dex231.htm EX-23.1 1533
5 GRAPHIC g230923g0929131713417.jpg GRAPHIC 2073
  Complete submission text file 0001193125-21-286789.txt   184879
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259882 | Film No.: 211292009
SIC: 2836 Biological Products, (No Diagnostic Substances)